Journal of Integrative Medicine ›› 2025, Vol. 23 ›› Issue (5): 502-518.doi: 10.1016/j.joim.2025.05.002
• Clinical Practice Guidelines • Previous Articles Next Articles
Sheng-sheng Zhang a, Lu-qing Zhao a, Xiao-hua Hou b, Zhao-xiang Bian c, Jian-hua Zheng d, Hai-he Tian e, Guan-hu Yang f, Won-sook Hong g, Yu-ying He h, Li Liu i, Hong Shen j, Yan-ping Li k, Sheng Xie l, Jin Shu m, Bin-fang Zeng n, Jun-xiang Li o, Zhen Liu p, Zheng-hua Xiao q, Jing-dong Xiao r, Pei-yong Zheng s, Shao-gang Huang t, Sheng-liang Chen u, Gui-jun Fei v#br#
| [1] | Meng-ting Xiao, Sen-yan Wang, Xiao-ling Wu, Zi-yu Zhao, Hui-min Wang, Hui-min Liu, Xue-mei Qin, Xiao-jie Liu. Antidepressant mechanism of Xiaoyaosan: A perspective from energy metabolism of the brain and intestine. Journal of Integrative Medicine, 2025, 23(6): 706-720. |
| [2] | Xin-ran Du, Meng-yi Wu, Mao-can Tao, Ying Lin, Chao-ying Gu, Min-feng Wu, Yi Cao, Da-can Chen, Wei Li, Hong-wei Wang, Ying Wang, Yi Wang, Han-zhi Lu, Xin Liu, Xiang-fei Su, Fu-lun Li. Clinical practice guidelines for the diagnosis and treatment of atopic dermatitis with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2025, 23(6): 641-653. |
| [3] | Hong-xia Ni, Lin-hai Cao, Xiao-xiao Gong, Zi-yan Zang, Hui Chang. Traditional Chinese medicine for treatment of type 2 diabetes mellitus: Clinical evidence and pharmacological mechanisms. Journal of Integrative Medicine, 2025, 23(6): 605-622. |
| [4] | Yue Jiang, Claire Chenwen Zhong, Betty Huan Wang, Shan-Shan Xu, Fai Fai Ho, Ming Hong Kwong, Leonard Ho, Joson Hao-Shen Zhou, K C Lam, Jian-Ping Liu, Bao-Ting Zhang, Vincent Chi Ho Chung. Methodological quality of systematic reviews on orally administered Chinese herbal medicine published in Chinese between 2021 and 2022: A cross-sectional study. Journal of Integrative Medicine, 2025, 23(5): 492-501. |
| [5] | Yan Han, Yu Wang, Mo-yi Shi, Yu Liu, Xiao-dong Cheng, Yang Zhou. Integrating traditional Chinese medicine constitutions into insomnia management: Findings from a cross-sectional study. Journal of Integrative Medicine, 2025, 23(4): 382-389. |
| [6] | Ya-ting Ai, Shi Zhou, Ming Wang, Tao-yun Zheng, Hui Hu, Yun-cui Wang, Yu-can Li, Xiao-tong Wang, Peng-jun Zhou. Development of a machine learning-based risk prediction model for mild cognitive impairment with spleen-kidney deficiency syndrome in the elderly. Journal of Integrative Medicine, 2025, 23(4): 390-397. |
| [7] | Man Liao, Li-ting Zhang, Li-juan Bai, Rui-yun Wang, Yun Liu, Jing Han, Li-hua Liu, Ben-ling Qi. Xuebijing injection reduces COVID-19 patients’ mortality as influenced by the neutrophil to lymphocyte platelet ratio. Journal of Integrative Medicine, 2025, 23(3): 282-288. |
| [8] | Cheng Zhang, Yi-sen Nie, Chuan-tao Zhang, Hong-jing Yang, Hao-ran Zhang, Wei Xiao, Guang-fu Cui, Jia Li, Shuang-jing Li, Qing-song Huang, Shi-yan Yan. An adaptive Bayesian randomized controlled trial of traditional Chinese medicine in progressive pulmonary fibrosis: Rationale and study design. Journal of Integrative Medicine, 2025, 23(2): 138-144. |
| [9] | Shi-yun Yan. Thoughts on the construction of flagship hospitals of integrated traditional Chinese and Western medicine in China. Journal of Integrative Medicine, 2025, 23(1): 12-14. |
| [10] | Ran Guo, Dian Zeng, Qi Zhao, Xin-yi Zhang, Xiao-ke Zhang, Yuan-li Liu. How are different traditional Chinese medicine modalities deployed by clinical practitioners in China? Findings from a national survey. Journal of Integrative Medicine, 2025, 23(1): 36-45. |
| [11] | Xuan Yin, Zhu Jin, Feng Li, Li Huang, Yan-mei Hu, Bo-chang Zhu, Zu-qing Wang, Xi-ying Li, Jian-ping Li, Lixing Lao, Yi-qun Mi, Shi-fen Xu. Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2024, 22(6): 637-644. |
| [12] | Yuan He, Xiao-xuan Qin, Ming-wei Liu, Wei Sun. Morin, a matrix metalloproteinase 9 inhibitor, attenuates endothelial-to-mesenchymal transition in atherosclerosis by downregulating Notch-1 signaling. Journal of Integrative Medicine, 2024, 22(6): 683-695. |
| [13] | Qiong Zhang, Ying-yi Fan, Xue-qing Wu, Yan-dan Huo, Chun-hui Wang, Shi-bing Liang, Ting Wang, Rong Zhong, Xuan Wang, Bao-yong Lai, Xiao-hua Pei, Jian-ping Liu. Hongjin Xiaojie Capsule, a Chinese patent medicine, for treating moderate to severe cyclical breast pain: A single-blind randomized controlled trial. Journal of Integrative Medicine, 2024, 22(5): 552-560. |
| [14] | Alexander L. Tournier, Leoni V. Bonamin, Susann Buchheim-Schmidt, Steven Cartwright, Christoph Dombrowsky, Paul Doesburg, Carla Holandino, Maria Olga Kokornaczyk, Everine B. van de Kraats, Jesús Antonio López-Carvallo, Papiya Nandy, José Manuel Mazón-Suástegui, Fateme Mirzajani, Bernard Poitevin, Claudia Scherr, Karin Thieves, Sandra Würtenberger, Stephan Baumgartner. Scientific guidelines for preclinical research on potentised preparations manufactured according to current pharmacopoeias—the PrePoP guidelines. Journal of Integrative Medicine, 2024, 22(5): 533-544. |
| [15] | Hui-zhi Zhu, Cheng-yi Li, Liang-ji Liu, Jia-bing Tong, Zhi-hui Lan, Shu-guang Tian, Qiao Li, Xiang-li Tong, Ji-feng Wu, Zhen-gang Zhu, Su-yun Li, Jian-sheng Li. Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2024, 22(5): 561-569. |
|